- Local governmentsIncreases State and Tribal authority over marijuana policy and local regulatory flexibility.
- Federal agenciesReduces federal criminal liability and forfeiture exposure for conduct compliant with State or Tribal law.
- Permitting processEnables interstate transportation between permitting jurisdictions, potentially expanding legal market access.
Strengthening the Tenth Amendment Through Entrusting States 2.0 Act
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Transportation and Infrastructure, for a period to be subsequently determ…
This bill (STATES 2.0 Act) amends the Controlled Substances Act to largely exempt marijuana that is produced, sold, or transported in compliance with State or qualifying Tribal law from most federal CSA provisions, deems such marijuana unschedulable, and directs rulemaking by the Attorney General and FDA. It preserves certain federal offenses (including specific transportation and youth-distribution provisions), creates exceptions, clarifies interstate transit between permitting States, requires FDA regulation of marijuana products, orders a GAO study on traffic safety, and protects compliant businesses from forfeiture, money-laundering and certain tax restrictions.
Progressives emphasize ending criminalization and tax relief benefits
Relative to its intended legislative type, this bill clearly establishes a substantive redefinition of the Controlled Substances Act's application to state- and tribe-compliant marijuana and lays out several concrete statutory changes and rulemaking deadlines, while leaving significant administrative, fiscal, and oversight details to subsequent agency action or future legislation.
This bill (STATES 2.0 Act) amends the Controlled Substances Act to largely exempt marijuana that is produced, sold, or transported in compliance with State or qualifying Tribal law from most federal CSA provisions, deems such marijuana unschedulable, and directs rulemaking by the Attorney General and FDA.
It preserves certain federal offenses (including specific transportation and youth-distribution provisions), creates exceptions, clarifies interstate transit between permitting States, requires FDA regulation of marijuana products, orders a GAO study on traffic safety, and protects compliant businesses from forfeiture, money-laundering and certain tax restrictions.
Substantive national drug-policy change with contested public-safety and federalism implications; plausible support exists but substantial procedural and political hurdles remain.
Relative to its intended legislative type, this bill clearly establishes a substantive redefinition of the Controlled Substances Act's application to state- and tribe-compliant marijuana and lays out several concrete statutory changes and rulemaking deadlines, while leaving significant administrative, fiscal, and oversight details to subsequent agency action or future legislation.
Progressives emphasize ending criminalization and tax relief benefits
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- StatesCould increase interstate diversion of marijuana into jurisdictions that still prohibit it.
- Potential burdenMay raise public health concerns, including youth access and impaired driving risks.
- Federal agenciesSubstantially narrows federal scheduling authority, raising potential legal and international treaty questions.
Why the argument around this bill splits.
Progressives emphasize ending criminalization and tax relief benefits
Likely broadly supportive because the bill reduces federal criminal exposure, removes scheduling for state-compliant marijuana, and ends tax and forfeiture penalties that harm small operators.
It also advances Tribal self-determination and requires FDA public-health oriented regulations.
Concerns would center on youth access, equity measures, and risks from interstate transport enabling diversion to prohibition States.
Generally favorable but pragmatic: the bill clarifies federal-state boundaries, reduces legal uncertainty for regulated businesses, and mandates FDA oversight and a GAO traffic study.
A centrist would want clearer guardrails on interstate diversion, funding for enforcement, and measured implementation timelines.
Mixed to skeptical: the Tenth Amendment framing and state autonomy aspects are appealing, but the bill’s effective federal de-scheduling and expanded interstate movement of marijuana raise concerns about national public safety, youth exposure, and reduced federal enforcement tools.
The FDA regulatory role and protections for compliant businesses may be seen as expanding federal influence and normalizing marijuana.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Substantive national drug-policy change with contested public-safety and federalism implications; plausible support exists but substantial procedural and political hurdles remain.
- No Congressional Budget Office cost estimate included
- Operational role and funding for TTB mentioned only in findings
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives emphasize ending criminalization and tax relief benefits
Substantive national drug-policy change with contested public-safety and federalism implications; plausible support exists but substantial…
Relative to its intended legislative type, this bill clearly establishes a substantive redefinition of the Controlled Substances Act's application to state- and tribe-compliant marijuana and lays out several concrete st…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.